Cannabis Use Tendency and Your Genetics

Cannabis Use Tendency Genetics | ExomeDNA

Genetic research has begun to uncover why cannabis use patterns vary considerably across populations. Large-scale genome-wide association studies now point to dozens of common genetic variants that, together, contribute to differences in cannabis use tendency — the population-level likelihood of ever using cannabis or using it regularly. Understanding these genetic influences offers a window into the neurobiology of reward, impulse regulation, and behavioral decision-making, without implying inevitability or moral judgment about any individual's choices.

What is cannabis use tendency?

Cannabis use tendency refers to the heritable component of an individual's likelihood of trying cannabis, continuing use, or using it frequently, as measured across large population studies. It is not a clinical label or a prediction of any specific behavior. Population research consistently finds that some people are genetically more inclined toward exploratory or sensation-seeking behaviors — of which cannabis use is one possible expression — while others are less so.

Importantly, genetics explains only a modest fraction of the variation in cannabis use across people. Social environment, peer networks, cultural context, access, and personal history all carry substantial weight. The genetic signal detected in research studies reflects underlying neurobiological tendencies — such as reward sensitivity and impulse regulation — rather than a direct instruction to use or avoid any substance.

ExomeDNA's Cannabis Use Tendency trait sits within the Behavior & Personality category, alongside related traits like alcohol use tendency, nicotine dependence risk, and risk-taking behavior. These traits share overlapping genetic architecture, which itself tells an important biological story.

The genetics behind cannabis use tendency

Cannabis use tendency is a polygenic trait, meaning it is influenced by many common genetic variants spread across the genome, each contributing a small effect. No single gene determines whether someone uses cannabis; instead, the cumulative signal from hundreds or thousands of variants shapes underlying neurobiological tendencies.

Among the most replicated loci, CADM2 (cell adhesion molecule 2) stands out as a gene associated across multiple behavioral and substance-use traits in large GWAS. CADM2 encodes a synaptic cell adhesion molecule expressed throughout the brain, and its variants have been linked not only to cannabis use but also to BMI, educational attainment, and risk tolerance — suggesting a broad role in the neural circuits that govern behavioral regulation and reward responsiveness.

NCAM1 (neural cell adhesion molecule 1) is another gene implicated in this trait's genetic architecture. NCAM1 is deeply involved in synaptic plasticity, learning, and memory, and participates in forming the dopaminergic circuits that underlie reward processing. Variants near NCAM1 have been associated with addiction vulnerability across multiple substances in independent research cohorts, pointing to a shared neurobiological pathway rather than substance-specific mechanisms.

Additional loci include AP2A2, which encodes a clathrin adaptor protein involved in receptor internalization in neurons, potentially affecting how neurotransmitter receptors are trafficked and recycled at synapses. The polygenic architecture of this trait as a whole likely reflects differences in reward sensitivity, impulse regulation, and stress-response pathways operating across multiple brain regions.

What the research says

Research base: Moderate.

Two landmark studies form the current evidence base for the genetic underpinnings of cannabis use tendency. The first, published in Translational Psychiatry in 2016, analyzed genome-wide data from more than 32,000 individuals across multiple cohorts assembled by the International Cannabis Consortium.

A 2016 meta-analysis of 32,330 participants identified the first genome-wide significant loci for lifetime cannabis use, establishing that cannabis use tendency has a meaningful heritable component detectable through population-level genetic studies.[1]

The second foundational study, published in Nature Neuroscience in 2018 and led by Pasman and colleagues, substantially expanded the discovery sample and applied bidirectional Mendelian randomization to test causal relationships between cannabis use and psychiatric traits.

The 2018 Nature Neuroscience GWAS identified new genome-wide significant risk loci for lifetime cannabis use and documented genetic overlap with schizophrenia, major depression, and other psychiatric traits, highlighting shared neurobiological pathways.[2]

For a full explanation of how ExomeDNA processes and weights genetic research, visit our methodology page.

It is important to note that population-level genetic associations do not translate into individual-level predictions. Those with higher polygenic scores for cannabis use tendency are not destined to use cannabis — they may simply carry variants that, across large populations, are more common among those who report cannabis use.

How cannabis use tendency affects you

A higher polygenic score for cannabis use tendency in population research is associated with higher rates of cannabis use among individuals carrying those variants — not with a fixed behavioral outcome for any one person. The trait reflects underlying neurobiological properties: how reward circuits respond to novel stimuli, how impulse regulation unfolds under stress, and how dopaminergic systems are calibrated.

Those with higher scores may carry genetic variants in loci like CADM2 and NCAM1 that are more common among cannabis users in large datasets. But environmental factors — family context, peer exposure, cultural norms, mental health history, and access — are estimated to account for the majority of individual variation. Genetics is a contributing factor, not a determining one.

It is equally important to acknowledge what this trait does not capture. Cannabis use tendency as measured genetically reflects population-level behavioral patterns, not personality flaws, character deficits, or clinical risk in any individual. The biology underlying this trait overlaps substantially with the biology of curiosity, novelty-seeking, and sensory engagement — traits that serve adaptive purposes across many contexts.

Related neurobiological traits — including impulsivity and dopamine sensitivity — share substantial genetic architecture with cannabis use tendency, reinforcing the picture of a broad reward-regulation system rather than a narrowly substance-specific biological pathway.

Working with your cannabis use tendency profile

Genetic information about behavioral tendencies is most useful as a starting point for self-awareness, not as a prescription or verdict. Those with higher polygenic scores for cannabis use tendency may find value in understanding the neurobiological underpinnings of reward-seeking and impulse regulation, which can inform conversations with clinicians, counselors, or health coaches about personalized approaches to stress management, behavioral health, and lifestyle choices.

For those who choose to use cannabis, awareness of genetic tendencies related to reward sensitivity may support more intentional decision-making. For those who prefer to avoid cannabis, knowing that some of the same underlying traits relate to creativity, novelty-seeking, or social engagement may open alternative channels for those biological drives.

Clinicians and genetic counselors working with individuals interested in behavioral health may find polygenic scores for cannabis use tendency useful as one data point among many, particularly when considered alongside family history, environmental context, and personal goals. No genetic score should be used in isolation to guide clinical recommendations.

Lifestyle factors including sleep quality, physical activity, and social support have documented effects on dopaminergic function and impulse regulation — the same neurobiological systems this trait reflects — providing actionable, evidence-based levers that are independent of genetic predisposition.

Related traits and genes

Cannabis use tendency does not exist in genetic isolation. The trait's architecture overlaps meaningfully with several others in the ExomeDNA Behavior & Personality category and beyond.

CADM2 variants appear in GWAS for alcohol use, educational attainment, BMI, and risk-taking behavior, suggesting that this locus influences a domain of behavioral regulation that is relevant across many life areas. NCAM1 has been implicated in addiction-related traits involving dopaminergic circuits across multiple substances, again pointing to shared rather than substance-specific mechanisms.

Closely related ExomeDNA traits include alcohol use tendency — which shares several genetic loci and reflects overlapping reward-system biology — as well as nicotine dependence risk and risk-taking behavior genetics, both of which capture partially overlapping neurobiological profiles.

Cross-category connections are equally important. Impulsivity genetics and dopamine sensitivity genetics represent the underlying neurobiological mechanisms — reward processing and behavioral inhibition — that likely mediate much of the cannabis use tendency signal detected in population GWAS. Understanding these connected traits together provides a more complete picture than any single score in isolation.

Frequently asked questions

Does a high cannabis use tendency score mean someone will use cannabis?

No. A higher polygenic score reflects patterns observed across large populations and does not predict individual behavior. Environmental, social, and personal factors account for the majority of real-world variation in cannabis use.

Which genes are most studied in relation to cannabis use tendency?

Current research highlights CADM2 and NCAM1 as among the most consistently replicated loci. CADM2 is associated with synaptic adhesion and behavioral regulation across multiple traits. NCAM1 is involved in dopaminergic circuit formation and synaptic plasticity. Additional loci including AP2A2 have been identified in large GWAS.

Is cannabis use tendency the same as cannabis addiction?

No. ExomeDNA's cannabis use tendency trait reflects the population-level genetic correlates of ever using cannabis or using it with some frequency, as measured in research cohorts. It does not assess clinical dependence, substance use disorder, or any clinical classification.

How heritable is cannabis use tendency?

Large twin and GWAS studies estimate that common genetic variants explain a modest but statistically detectable proportion of variance in cannabis use. Environmental factors — including social context, access, and cultural norms — account for a larger share of variation than genetics alone.

Does the genetics of cannabis use tendency overlap with mental health genetics?

Population research has documented genetic overlap between cannabis use tendency and several psychiatric traits. A 2018 Nature Neuroscience study found shared genetic architecture with schizophrenia and depression, and evidence of causal relationships in some directions using Mendelian randomization methods. This overlap reflects shared neurobiological pathways, not a simple cause-and-effect relationship at the individual level.[2]

Can lifestyle changes influence the behavioral tendencies this trait reflects?

Yes. The neurobiological systems this trait reflects — including dopaminergic reward circuits and impulse regulation pathways — respond to lifestyle factors such as physical activity, sleep quality, and stress management. Genetic predispositions are not fixed determinants of behavior.